title: Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
abstract: Tumour necrosis factor (TNF), a key regulator of varied physiological mechanisms in multiple organ systems, is an immune signalling molecule produced by glia, neurons, macrophages and other immune cells. In the brain, among other functions, TNF serves as a gliotransmitter, secreted by glial cells that envelope and surround synapses, which regulates synaptic communication between neurons. The role of TNF as a gliotransmitter may help explain the profound synaptic effects of TNF that have been demonstrated in the hippocampus, in the spinal cord and in a variety of experimental models. Excess TNF is present in the CSF of individuals with Alzheimer's disease (AD), and has been implicated as a mediator of the synaptic dysfunction that is hypothesized to play a central role in the pathogenesis of AD. TNF may also play a role in endothelial and microvascular dysfunction in AD, and in amyloidogenesis and amyloid-induced memory dysfunction in AD. Genetic and epidemiological evidence has implicated increased TNF production as a risk factor for AD. Perispinal administration of etanercept, a potent anti-TNF fusion protein, produced sustained clinical improvement in a 6-month, open-label pilot study in patients with AD ranging from mild to severe. Subsequent case studies have documented rapid clinical improvement following perispinal etanercept in both AD and primary progressive aphasia, providing evidence of rapidly reversible, TNF-dependent, pathophysiological mechanisms in AD and related disorders. Perispinal etanercept for AD merits further study in randomized clinical trials.
authors.affiliation: Institute for Neurological Research, Los Angeles, California 90095, USA. etmd@ucla.edu
authors.forename: Edward
authors.initials: E
authors.lastname: Tobinick
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D016503:Drug Delivery Systems; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D009435:Synaptic Transmission; D014409:Tumor Necrosis Factor-alpha / Q000134:cerebrospinal fluid / Q000378:metabolism*
chemical_list: D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept
references.citation: Neurology. 2007 May 29;68(22):1902-8
references.pmid: 17536046
references.citation: J Immunol. 1990 Apr 15;144(8):2999-3007
references.pmid: 2109008
references.citation: Am J Pathol. 2007 Jan;170(1):388-98
references.pmid: 17200210
references.citation: Mech Ageing Dev. 2006 Jun;127(6):567-71
references.pmid: 16516271
references.citation: Ital J Anat Embryol. 2006 Oct-Dec;111(4):221-46
references.pmid: 17385278
references.citation: Biochem Soc Trans. 2007 Nov;35(Pt 5):1219-23
references.pmid: 17956317
references.citation: J Neurochem. 2000 Feb;74(2):457-71
references.pmid: 10646496
references.citation: Neurology. 2001 Nov 27;57(10):1885-8
references.pmid: 11723281
references.citation: J Psychiatr Res. 1975 Nov;12(3):189-98
references.pmid: 1202204
references.citation: Arch Neurol. 2006 Aug;63(8):1165-9
references.pmid: 16908746
references.citation: Anat Rec. 1997 Oct;249(2):285-94
references.pmid: 9335475
references.citation: Nat Med. 2003 Oct;9(10):1245-50
references.pmid: 14520364
references.citation: FASEB J. 1999 Jan;13(1):63-8
references.pmid: 9872930
references.citation: Br J Clin Psychol. 2000 Jun;39(2):181-91
references.pmid: 10895361
references.citation: Am J Med Genet. 2002 Jul 8;114(5):574-7
references.pmid: 12116197
references.citation: Synapse. 2000 Feb;35(2):151-9
references.pmid: 10611641
references.citation: J Neurosci. 2006 Jan 4;26(1):246-55
references.pmid: 16399694
references.citation: Neurosci Lett. 1992 Nov 9;146(2):176-8
references.pmid: 1337194
references.citation: Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70
references.pmid: 1103152
references.citation: Arch Clin Neuropsychol. 2006 Aug;21(5):413-20
references.pmid: 16843636
references.citation: Science. 2002 Oct 25;298(5594):789-91
references.pmid: 12399581
references.citation: Arch Clin Neuropsychol. 2004 Aug;19(5):703-8
references.pmid: 15330000
references.citation: Clin Neuropsychol. 2004 Feb;18(1):122-31
references.pmid: 15595364
references.citation: Prog Neurobiol. 1999 Jun;58(3):233-47
references.pmid: 10341362
references.citation: Ann N Y Acad Sci. 2007 Feb;1097:40-50
references.pmid: 17413008
references.citation: Neurology. 1999 Aug 11;53(3):457-65
references.pmid: 10449104
references.citation: Nature. 2006 Apr 20;440(7087):1054-9
references.pmid: 16547515
references.citation: Am J Roentgenol Radium Ther Nucl Med. 1957 Aug;78(2):195-212
references.pmid: 13444513
references.citation: BMC Res Notes. 2009 Feb 27;2:28
references.pmid: 19284700
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3410-5
references.pmid: 16492745
references.citation: Brain Res. 1989 Jul 10;491(2):394-7
references.pmid: 2765895
references.citation: Nat Rev Neurosci. 2005 Aug;6(8):626-40
references.pmid: 16025096
references.citation: J Neurosci Res. 2008 Oct;86(13):2867-75
references.pmid: 18543334
references.citation: Curr Med Res Opin. 2004 Jul;20(7):1075-85
references.pmid: 15265252
references.citation: Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):335-43
references.pmid: 17493863
references.citation: Bioorg Med Chem Lett. 2007 Jan 15;17(2):414-8
references.pmid: 17079143
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):873-83
references.pmid: 11754994
references.citation: J Neurosci. 2007 May 16;27(20):5394-404
references.pmid: 17507561
references.citation: J Neurosci. 2001 Feb 15;21(4):1179-88
references.pmid: 11160388
references.citation: Trends Mol Med. 2005 Apr;11(4):170-6
references.pmid: 15823755
references.citation: J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1200-5
references.pmid: 12933918
references.citation: Am J Pathol. 2008 Dec;173(6):1768-82
references.pmid: 18974297
references.citation: J Neurosci. 2005 Mar 23;25(12):3219-28
references.pmid: 15788779
references.citation: Ann Surg. 1940 Jul;112(1):138-49
references.pmid: 17857618
references.citation: Pharmacol Ther. 2008 Feb;117(2):244-79
references.pmid: 18155297
references.citation: MedGenMed. 2006 Apr 26;8(2):25
references.pmid: 16926764
references.citation: Drug Discov Today. 2009 Feb;14(3-4):168-77
references.pmid: 19027875
references.citation: Neuron. 2004 Sep 30;44(1):181-93
references.pmid: 15450169
references.citation: J Neurosci. 2006 Jan 11;26(2):662-70
references.pmid: 16407564
references.citation: Trends Neurosci. 2007 Aug;30(8):417-24
references.pmid: 17631972
references.citation: J Rheumatol. 2007 Jan;34(1):239-40; discussion 240
references.pmid: 17216704
references.citation: MedGenMed. 2006 Feb 22;8(1):53
references.pmid: 16915183
references.citation: Brain Behav Immun. 2007 Mar;21(3):281-9
references.pmid: 17275255
references.citation: Arch Neurol. 1994 Jan;51(1):41-5
references.pmid: 8274108
references.citation: Behav Brain Res. 2008 May 16;189(1):100-6
references.pmid: 18325608
references.citation: Biochem Biophys Res Commun. 1991 Dec 31;181(3):1532-8
references.pmid: 1662500
references.citation: Trends Mol Med. 2008 Mar;14(3):103-8
references.pmid: 18262842
references.citation: J Clin Immunol. 1999 Jul;19(4):223-30
references.pmid: 10471976
references.citation: Nat Neurosci. 2006 Feb;9(2):260-7
references.pmid: 16388306
references.citation: J Neurosci. 2005 Mar 16;25(11):2952-64
references.pmid: 15772355
references.citation: J Cell Biol. 2007 Aug 27;178(5):829-41
references.pmid: 17724122
references.citation: J Neuroinflammation. 2008 Jan 09;5:2
references.pmid: 18184433
references.citation: Clin Ther. 2003 Aug;25(8):2279-88
references.pmid: 14512134
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6828-33
references.pmid: 17420446
references.citation: Nature. 1998 Feb 26;391(6670):892-6
references.pmid: 9495341
references.citation: J R Soc Interface. 2009 Aug 6;6(37):655-68
references.pmid: 18986963
references.citation: Exp Physiol. 2005 Sep;90(5):663-70
references.pmid: 15944202
references.citation: Eur J Pharmacol. 2006 Sep 1;545(1):11-21
references.pmid: 16887118
references.citation: Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):174-83
references.pmid: 11723368
references.citation: Neurobiol Dis. 2005 Jun-Jul;19(1-2):129-41
references.pmid: 15837568
references.citation: Neurobiol Aging. 2001 Jul-Aug;22(4):671-6
references.pmid: 11445267
references.citation: Clin Neuropsychol. 2007 Jul;21(4):587-616
references.pmid: 17613980
references.citation: J Am Geriatr Soc. 2005 Apr;53(4):695-9
references.pmid: 15817019
references.citation: Eur Neurol. 2008;59(1-2):91-3
references.pmid: 17934280
references.citation: NeuroRx. 2005 Jan;2(1):3-14
references.pmid: 15717053
references.citation: J Neural Transm (Vienna). 2006 Nov;113(11):1709-15
references.pmid: 16736247
references.citation: Brain Res. 2005 Aug 16;1053(1-2):54-61
references.pmid: 16040010
references.citation: Curr Alzheimer Res. 2004 Feb;1(1):27-32
references.pmid: 15975082
references.citation: Neuropsychology. 1998 Apr;12(2):259-67
references.pmid: 9556772
references.citation: Glia. 2007 Sep;55(12):1214-21
references.pmid: 17659528
references.citation: PLoS One. 2008;3(11):e3604
references.pmid: 18978948
references.citation: Neurology. 1996 Dec;47(6):1531-4
references.pmid: 8960740
references.citation: Int J Geriatr Psychiatry. 2004 Jan;19(1):41-50
references.pmid: 14716698
references.citation: Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5
references.pmid: 2529544
references.citation: BMC Neurol. 2008 Jul 21;8:27
references.pmid: 18644112
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841
references.citation: Brain Res. 2005 Feb 9;1034(1-2):11-24
references.pmid: 15713255
references.citation: Nat Neurosci. 2003 Jan;6(1):43-50
references.pmid: 12469126
references.citation: Curr Alzheimer Res. 2007 Dec;4(5):550-2
references.pmid: 18220520
references.citation: Trends Mol Med. 2007 Feb;13(2):54-63
references.pmid: 17207662
references.citation: Ann Rheum Dis. 2009 Mar;68(3):362-6
references.pmid: 18390569
references.citation: J Neurosci. 2005 Mar 9;25(10):2566-75
references.pmid: 15758166
references.citation: Appl Neuropsychol. 1999;6(4):247-51
references.pmid: 10635440
references.citation: Science. 2002 Mar 22;295(5563):2282-5
references.pmid: 11910117
references.citation: Anesth Analg. 2006 Mar;102(3):973-4
references.pmid: 16492873
references.citation: FASEB J. 2006 Mar;20(3):494-6
references.pmid: 16423877
references.citation: Spine (Phila Pa 1976). 2004 Jul 1;29(13):1465-71
references.pmid: 15223940
references.citation: J Neurosurg. 1997 Feb;86(2):252-62
references.pmid: 9010427
references.citation: Swiss Med Wkly. 2003 Mar 22;133(11-12):170-7
references.pmid: 12715286
references.citation: Neuroimmunomodulation. 1995 May-Jun;2(3):161-5
references.pmid: 8646566
references.citation: Ann Neurol. 1980 May;7(5):486-8
references.pmid: 7396427
references.citation: Medscape J Med. 2008 Jun 10;10(6):135
references.pmid: 18679537
references.citation: Hum Mutat. 2005 Jul;26(1):29-35
references.pmid: 15895461
references.citation: Am J Pathol. 2007 Feb;170(2):680-92
references.pmid: 17255335
references.citation: Prog Neurobiol. 2000 Feb;60(2):109-37
references.pmid: 10639051
references.citation: Neuron. 2007 Feb 1;53(3):337-51
references.pmid: 17270732
references.citation: Eur J Neurosci. 2005 Dec;22(11):2827-32
references.pmid: 16324117
references.citation: Pharm Res. 2005 Jul;22(7):1011-37
references.pmid: 16028003
references.citation: J Neurosurg. 1951 Jul;8(4):411-22
references.pmid: 14851015
references.citation: Clin Neuropsychol. 2008 May;22(3):507-18
references.pmid: 17853128